Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)

QR Code

Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)

None

Saved in:

Bibliographic Details
Main Authors:	Fujii, Hideaki, Hirayama, Shigeto, Nagase, Hiroshi
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/32121
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Models of neuroinflammation for the assessment of kappa-opioid receptor ligands
by: K. Yu. Kalitin, et al.
Published: (2023-05-01)

The effects of kappa opioid agonist RU-1205 on local field potentials and behavior in the discriminative stimulus paradigm
by: K. Yu. Kalitin, et al.
Published: (2025-07-01)

The significance of Trk receptors in pancreatic cancer
by: Matthew D Johnson, et al.
Published: (2017-02-01)

Involvement of TRK receptors in the nootropic effect of cycloprolylglycine
by: O. N. Vorontsova, et al.
Published: (2025-01-01)

Research of neuroprotective properties of TrkA-receptor agonist GK-2 on model of oxidative stress in human vascular endothelial cells (HUVEC)
by: T. A. Antipova, et al.
Published: (2019-01-01)

Molecular Aspects of Opioid Receptors and Opioid Receptor Painkillers
by: Yongye, Austin B., et al.
Published: (2012)

Effects of a kappa opioid receptor antagonist on delayed postoperative pain recovery in a novel mouse sleep disorder model
by: Hisakatsu Ito, et al.
Published: (2025-07-01)

Electrophysiological effects of kappa-opioid analgesic, RU-1205, using machine learning methods
by: K. Yu. Kalitin, et al.
Published: (2024-01-01)

Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review
by: Vahid Ashoorion, et al.
Published: (2025-12-01)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01)

Cardioprotective effect of peptide and non-peptide opioid receptor agonists in cardiac reperfusion: potential clinical application of experimental data
by: A. V. Mukhomedzyanov, et al.
Published: (2025-05-01)

Alternative TrkA Splicing and Neuroblastoma
by: Farina, Antonietta R., et al.
Published: (2012)

PHARMACOKINETIC PROPERTIES OF A NEW KAPPA-OPIOID ANALGESIC RU-1205 COMPOUND AT A SINGLE PERORAL ADMINISTRATION
by: A. A. Spasov, et al.
Published: (2021-07-01)

Selective opioid agonist Taphalgin® as a component of postoperative analgesia in various surgical areas: “NIKITA” observational multicenter study
by: A. E. Karelov, et al.
Published: (2024-08-01)

Assessment of the feed additives thiamine hydrochloride (3a820) and thiamine mononitrate (3a821) (vitamin B1) for all animal species for the renewal of their authorisation (Kaesler Nutrition GmbH)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2025-04-01)

Molecular mechanisms of novel selective glucocorticoid receptor agonist action in breast cancer cells
by: E. M. Zhidkova, et al.
Published: (2024-10-01)

Place of imidazoline receptor agonists in the treatment of hypertension
by: D. V. Nebieridze, et al.
Published: (2022-01-01)

Imidazoline receptor agonists and left ventricular hypertrophy
by: L. L. Kirichenko, et al.
Published: (2005-04-01)

Effects of a New Kappa Agonist (Fluorophenyl Derivative of Imidazo[1,2-<i>а</i>]benzimidazole) on the Rat Genome
by: O. V. Verle, et al.
Published: (2023-03-01)

New treatment options for pulmonary arterial hypertension — the first selective IP-receptor agonist selexipag
by: N. V. Ilyin, et al.
Published: (2019-12-01)

Assessment of the feed additives thiamine hydrochloride (3a820) and thiamine mononitrate (3a821) (vitamin B1) for all animal species for the renewal of their authorisation (DSM Nutritional Products Ltd. and Orffa Additives BV)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2025-04-01)

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

BDNF/TrkB signaling in stable coronary artery disease
by: O. V. Atamas, et al.
Published: (2023-12-01)

The role of μ-opioid receptors in the regulation of hepatic secretory function
by: M. A. Medvedev, et al.
Published: (2006-06-01)

Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
by: S. I. Zabroda, et al.
Published: (2015-07-01)

Advanced mutant receptor activator of nuclear factor kappa‐Β ligand development with low affinity for osteoprotegerin
by: Yuria Jang, et al.
Published: (2025-01-01)

The Contribution of Brain-Derived Neurotrophic Factor (BDNF) and its TrkB Receptor to Hippocampal Neuron Resistance to Ischemia-Reperfusion (Experimental Study)
by: Irina V. Ostrova, et al.
Published: (2018-12-01)

Anticancer activity of tyrosine kinase TrkA receptors antagonist GK-1 in experiment on mice with mammary gland adenocarcinoma Ca755
by: L. P. Kovalenko, et al.
Published: (2024-11-01)

Imidazoline receptor agonists: more than blood pressure reduction?
by: D. V. Nebieridze, et al.
Published: (2006-04-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

On Extended d-D Kappa Distribution
by: Arak M. Mathai, et al.
Published: (2025-07-01)

Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology
by: A. V. Tarasiuk, et al.
Published: (2023-01-01)

RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01)

Drug Design Approaches to Manipulate the Agonist-Antagonist Equilibrium in Steroid Receptors
by: Lusher, Scott J., et al.
Published: (2012)

Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy
by: A. N. Britov, et al.
Published: (2006-02-01)

Inhibition of Advanced Prostate Cancer by Androgens and Liver X Receptor Agonists
by: Chuu, Chih-Pin, et al.
Published: (2011)

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
by: Е. L. Nasonov, et al.
Published: (2024-04-01)

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations
by: Sarah L Anderson
Published: (2025-07-01)